hrs4r
Quiero donar

ANA MERINO RIBAS

Firma
ANA MERINO-RIBAS
Posición
Investigador/a Post-doctoral – R2
Investigadores/as Post-doctorales – R2

Projectes

Codi oficial: MICROPOLI Data inicio:11/08/2021 Data fi: 11/08/2026 Investigador/a principal: ANA MERINO RIBAS Organisme finançador: FUNDACIÓN SENEFRO

Publicacions

Merino-Ribas, A, Fumagalli, A, Fernandez-Real, JM, Valenti, S, Vallmajo, A, Saltos, JJA, Cantalejo, LG, Alemany, NM, Suárez, GMG, Castillo, CM, Acosta, Y, Martínez, JC

Exploring prognostic markers in autosomal dominant polycystic kidney disease

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025, 40 dx.doi.org/10.1093/ndt/gfaf116.1057
Saltos, JJA, Suárez, GMG, Devia, CMC, Alemany, NM, Ribas, AM, Paez, CN, Cantalejo, LG, Baptista, YAA, Vallmajor, MC, Martínez, JC

Congestion parameters in a peritoneal dialysis program

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025, 40 dx.doi.org/10.1093/ndt/gfaf116.1792
Araujoa, R, Merino-Ribasa, A, Pereiraa, L, Camposa, J, Silva, N, Alencastrea, IS, Pestanaa, M, Sampaio-Maia, B

The urogenital microbiome in chronic kidney disease patients on peritoneal dialysis

Nefrologia, 2024, 44, 194-203 dx.doi.org/10.1016/j.nefro.2023.08.008
Gomez-Preciado, F, Martinez-Valenzuela, L, Anton-Pampols, P, Fulladosa, X, Tena, M, Gomà, M, Jove, M, Nadal, E, Merino-Ribas, A, Martin-Alemany, N, Cruzado, J, Torras, J, Draibe, J

Urinary soluble PD-1 as a biomarker of checkpoint inhibitor-induced acute tubulointerstitial nephritis

Clinical Kidney Journal, 2024, 17 dx.doi.org/10.1093/ckj/sfae200
Cantalejo, LG, Paez, CN, Suárez, GMG, Ribas, AM, Alemany, NM, Carcasi, MLC, Devia, CMC, Baptista, YAA, Saltos, JJA, Soler, LB, Martínez, JC

Preoperative ultrasound vascular mapping as a predictor of arteriovenous fistula survival: a prospective cohort study

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39, 1317-1317 dx.doi.org/10.1093/ndt/gfae069.800
Martínez, JC, Saltos, JJA, Carcasi, MLC, Ribas, AM, Alemany, NM, Suárez, GMG, Cantalejo, LG, Devia, CMC, Paez, CN, Soler, LB, Baptista, YAA, Escuder, PT

Describing inflammatory markers in end-stage renal disease and hemodialysis

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39, 1107-1107 dx.doi.org/10.1093/ndt/gfae069.677
Ribas, AM, Sampaio, S, Araujo, R, Azevedo, MJ, Alencastre, I, Pestana, M, Ximénez-Embún, P, Muñoz, J, Sampaio-Maia, B, Trindade, F

The association between oral proteome and microbiome in kidney transplant recipients: 24-months prospective study

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39, 1561-1561 dx.doi.org/10.1093/ndt/gfae069.954
Martínez, JC, Saltos, JJA, Ribas, AM, Carcasi, MLC, Alemany, NM, Barrera, JB, Cantalejo, LG, Soler, LB, Suárez, GMG, Paez, CN, Devia, CMC, Baptista, YAA

A change in the paradigm of onconephrology

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39, 699-699 dx.doi.org/10.1093/ndt/gfae069.423
Draibe JB, Marco H, Ibernon M, Agraz I, Arcal C, Barros X, Cabrera V, Da Silva I, Díaz M, Fulladosa X, Guillén E, Lescano P, Valenzuela LM, Márquez E, Martín N, Merino A, Navarro M, Rodríguez E, Soler MJ, Torras J, Quintana LF

Diagnosis and Treatment of Renal ANCA Vasculitis: A Summary of the Consensus Document of the Catalan Group for the Study of Glomerular Diseases (GLOMCAT).

Journal of Clinical Medicine, 2024, 13 dx.doi.org/10.3390/jcm13226793
Araujo R, Ribas AM, Sampaio S, Silva N, Campos J, Pestana M, Maia BS

The stability of the gut, oral, and circulating microbiomes in living kidney donors: A 2 years prospective study

CLINICAL TRANSPLANTATION, 2023, 37 dx.doi.org/10.1111/ctr.15084

Formulari de contacte

Conoce el IDIBGI!

menu